These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36104120)

  • 1. Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?
    Fazzari MJ; Guerra MM; Salmon J; Kim MY
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
    Buyon JP; Kim MY; Guerra MM; Laskin CA; Petri M; Lockshin MD; Sammaritano L; Branch DW; Porter TF; Sawitzke A; Merrill JT; Stephenson MD; Cohn E; Garabet L; Salmon JE
    Ann Intern Med; 2015 Aug; 163(3):153-63. PubMed ID: 26098843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential genetic biomarkers predict adverse pregnancy outcome during early and mid-pregnancy in women with systemic lupus erythematosus.
    Deng Y; Zhou Y; Shi J; Yang J; Huang H; Zhang M; Wang S; Ma Q; Liu Y; Li B; Yan J; Yang H
    Front Endocrinol (Lausanne); 2022; 13():957010. PubMed ID: 36465614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and Systemic Lupus Erythematosus.
    Petri M
    Best Pract Res Clin Obstet Gynaecol; 2020 Apr; 64():24-30. PubMed ID: 31677989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of the safety of tacrolimus use and its optimal cut-off concentration during pregnancy in women with systemic lupus erythematosus: study from two Japanese tertiary referral centers.
    Nakai T; Honda N; Soga E; Fukui S; Kitada A; Yokogawa N; Okada M
    Arthritis Res Ther; 2024 Jan; 26(1):15. PubMed ID: 38178242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study.
    Larosa M; Le Guern V; Guettrot-Imbert G; Morel N; Abisror N; Morati-Hafsaoui C; Orquevaux P; Diot E; Doria A; Sarrot-Reynauld F; Limal N; Queyrel V; Souchaud-Debouverie O; Sailler L; Le Besnerais M; Goulenok T; Molto A; Pannier-Metzger E; Sentilhes L; Mouthon L; Lazaro E; Costedoat-Chalumeau N;
    Rheumatology (Oxford); 2022 Aug; 61(9):3657-3666. PubMed ID: 35015828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
    Yelnik CM; Porter TF; Branch DW; Laskin CA; Merrill JT; Guerra MM; Lockshin MD; Buyon JP; Petri M; Sammaritano LR; Stephenson MD; Kim MY; Salmon JE
    Arthritis Rheumatol; 2016 Aug; 68(8):1964-9. PubMed ID: 26990620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER).
    Laíño-Piñeiro MC; Rúa-Figueroa I; Jiménez N; Lozano MJC; Martínez-Barrio J; Serrano B; Galindo-Izquierdo M; Nack A; Loricera J; Tomero-Muriel E; Ibáñez-Barceló M; Vázquez NM; Manrique-Arija S; Lorenzo NA; Narváez J; Rosas J; Menor-Almagro R; Martínez-Taboada VM; Aurrecoechea-Aguinaga E; Horcada L; Ruiz-Lucea E; Raya E; Toyos FJ; Expósito L; Vela P; Freire-González M; Moriano-Morales C; Bonilla-Hernán G; Ibáñez TC; Lozano-Rivas N; Moreno M; Andreu JL; Ubiaga CLI; Torrente-Segarra V; Valls E; Velloso-Feijoo ML; Alcázar JL; Pego-Reigosa JM
    Semin Arthritis Rheum; 2023 Aug; 61():152232. PubMed ID: 37348350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal.
    Braga A; Barros T; Faria R; Marinho A; Carvalheira G; Rocha G; Farinha F; Neves E; Vasconcelos C; Braga J
    Lupus; 2021 Nov; 30(13):2165-2175. PubMed ID: 34693803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
    Li X; Shopit A; Wang J
    Arch Gynecol Obstet; 2021 Nov; 304(5):1153-1160. PubMed ID: 34390384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancies in women with systemic lupus erythematosus and antiphospholipid antibodies.
    Schreiber K
    Lupus; 2016 Apr; 25(4):343-5. PubMed ID: 26811370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
    Kim MY; Guerra MM; Kaplowitz E; Laskin CA; Petri M; Branch DW; Lockshin MD; Sammaritano LR; Merrill JT; Porter TF; Sawitzke A; Lynch AM; Buyon JP; Salmon JE
    Ann Rheum Dis; 2018 Apr; 77(4):549-555. PubMed ID: 29371202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
    Lockshin MD; Kim M; Laskin CA; Guerra M; Branch DW; Merrill J; Petri M; Porter TF; Sammaritano L; Stephenson MD; Buyon J; Salmon JE
    Arthritis Rheum; 2012 Jul; 64(7):2311-8. PubMed ID: 22275304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center.
    Barilaro G; Castellanos A; Gomez-Ferreira I; Lledó GM; Della Rocca C; Fernandez-Blanco L; Cervera R; Baños N; Figueras F; Espinosa G
    Arthritis Res Ther; 2022 Apr; 24(1):91. PubMed ID: 35477585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of adverse pregnancy outcome in a cohort of women with systemic lupus erythematosus in Malaysia.
    Ong SG; Ding HJ
    Med J Malaysia; 2021 Jul; 76(4):466-473. PubMed ID: 34305106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.
    Kaplowitz ET; Ferguson S; Guerra M; Laskin CA; Buyon JP; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Merrill JT; Katz P; Salmon JE
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):230-235. PubMed ID: 28480528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE).
    Conklin J; Golpanian M; Engel A; Izmirly P; Belmont HM; Dervieux T; Buyon JP; Alexander RV
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36755365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes.
    Castellanos Gutierrez AS; Figueras F; Espinosa G; Youssef L; Crispi F; Santana M; Nadal A; Baños N
    Placenta; 2023 Aug; 139():92-98. PubMed ID: 37354691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.